Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

Steven W. Lockley, Marlene Dressman, Louis Licamele, Changfu Xiao, Dennis M. Fisher, Erin E. Flynn‐Evans, Joseph T. Hull, Rosarelis Torres, Christian Lavedan, Mihael H. Polymeropoulos

The Lancet · 2015 · 293 citations · 32 references

Concepts

References

32